AHA Center for Health Innovation
Learn how Mark Cuban is disrupting drug pricing and making waves in the pharmaceutical industry. Find out more about his Cost Plus Drugs company and its collaborations with payers and pharmacists.
A recently released blueprint from the Coalition for Healthcare AI (CHAI) aims to provide guidance and guardrails to ensure ethical, unbiased and appropriate use of the technology in health care. CHAI and the National Association of Medicine coordinated with experts from academic medical centers,…
Insights on the national effort to dismantle structural racism and provides resources to advance health equity in hospitals and health systems.
Health IT leaders, startups and well-established health care companies recently met in Nashville at the ViVE Conference to accelerate innovation and harness the power of data and technology in health care.
To address the issue of pregnant Black people experiencing severe complications and dying at higher rates, Akron General recently became one of four hospitals in the country to implement a new care model designed to improve outcomes for pregnant patients by focusing on communication and teamwork to…
Beyond reimagining health care through a consumer lens, it’s important to research what will move the needle on issues like patient loyalty, trust and satisfaction, notes a recent McKinsey & Company report.
A new database created by the U.S. Census Bureau’s Enhancing Health (EHealth) Data Program and the Centers for Disease Control and Prevention’s National Center for Health Statistics (NCHS) aims to bring context to how the number of retail health clinics (RHCs) has accelerated in recent years.
In 2017, the American Medical Association developed new hospital food guidelines, aiming to engage hospitals in the effort for better nutrition to fight cancer and cardiovascular disease. This webinar will outline the importance of these guidelines and practical steps for implementation. (Webinar…
Innovative community-centered partnerships and creative investment strategies can mitigate health disparities that adversely affect excluded or marginalized groups. And many health systems are using these approaches to achieve powerful results, notes a recent NEJM Catalyst analysis.
The state of California put up $50 million to have Civica Rx manufacture and distribute low-cost biosimilars for the three most used short- and long-acting insulins.